Xuetongsu attenuates bone destruction in collagen-induced arthritis mice by inhibiting osteoclast differentiation and promoting osteoclast apoptosis. 2024

Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Materia Medica Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.

Tujia ethnomedicine Xuetong (the stems of Kadsura heteroclita) have been widely used in folk for rheumatoid arthritis (RA), which can alleviate rheumatic pain through liquor soaking in folk. In this study, we aimed to evaluate the pharmacological effects and underlying mechanism of Xuetongsu (a key chemical component of Xuetong) on bone destruction. In our previous study, it was found that Xuetong extract can reduce adjuvant arthritic rats paw swelling and inhibit inflammatory factors in serum. Furthermore, Xuetongsu has been demonstrated to inhibit the proliferation of fibroblast-like synoviocytes, but its potential to inhibit bone destruction has not been explored. To address this, we employed the STRING database to predict protein interactions and utilized Autodock software to simulate the binding of Xuetongsu to target proteins. In this study, administration of Xuetongsu significantly alleviated paw swelling and bone destruction in C57BL/6 mice with collagen-induced arthritis (CIA). Mechanistic studies have indicated that Xuetongsu promotes apoptosis of mature osteoclasts in joint tissues by activating Caspase-3 and Bax, while inhibiting Bcl-2. Additionally, Xuetongsu inhibits osteoclast differentiation by suppressing RANKL, RANK, P-NF-κB, and NFATc1, and reduces bone resorption activity by inhibiting MMP-9, CTSK, and TRAP. Importantly, Xuetongsu exhibits good biocompatibility in major organs of mice. In summary, Xuetongsu has the potential to treat bone destruction by promoting apoptosis of mature osteoclasts, inhibiting osteoclast differentiation, and reducing bone resorption. This study reveals the pharmacological effects of Xuetongsu and its mechanism of action, which may contribute to the development of novel approaches for treating RA.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D053245 RANK Ligand A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B and OSTEOPROTEGERIN. It plays an important role in regulating OSTEOCLAST differentiation and activation. Tumor Necrosis Factor Ligand Superfamily Member 11,CD254 Antigen,OPGL Protein,Osteoclast Differentiation Factor,Osteoprotegerin Ligand,RANKL Protein,Receptor Activator of Nuclear Factor-kappa B Ligand,Receptor Activator of Nuclear Factor-kappaB Ligand,TNF Superfamily, Member 11,TRANCE Protein,Tumor Necrosis Factor-Related Activation-Induced Cytokine,Antigen, CD254,Differentiation Factor, Osteoclast,Receptor Activator of Nuclear Factor kappa B Ligand,Receptor Activator of Nuclear Factor kappaB Ligand,Tumor Necrosis Factor Related Activation Induced Cytokine

Related Publications

Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
February 2015, International immunopharmacology,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
September 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
December 2023, JBMR plus,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
March 2021, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
January 2020, Biological & pharmaceutical bulletin,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
January 2020, Bone,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
January 2023, Open life sciences,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
May 2021, International journal of molecular sciences,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
February 2010, British journal of pharmacology,
Hao Zheng, and Yunzhe Li, and Yasi Deng, and Huanjie Li, and Xinyang Shen, and Haokai Lin, and Yong Yang, and Xing Tian, and Bin Li, and Hanwen Yuan, and Wenbing Sheng, and Wei Wang, and Huanghe Yu
September 2020, Journal of cellular physiology,
Copied contents to your clipboard!